Gelonghui, December 13: Jiangsu Wuzhong (600200.SH) announced that the Suzhou Pharmaceutical Factory of Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. (“Suzhou Pharmaceutical Factory” for short) participated in the national centralized drug procurement process organized by the Joint Pharmaceutical Procurement Office of the State Organization. Suzhou Pharmaceutical Factory has passed the consistent evaluation of the quality and efficacy of generic drugs by the State Drug Administration to win the bid for this centralized procurement of dobutamine hydrochloride injections and paramivir injections.
江苏吴中(600200.SH)：所属公司参加全国药品集中采购拟中标
JiangSu WuZhong Pharmaceutical Development (600200.SH): The affiliated company participated in the national Pharmaceutical centralized procurement and plans to win the bid.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.